<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25821355</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1466-1861</ISSN><JournalIssue CitedMedium="Internet"><Volume>2015</Volume><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Mediators of inflammation</Title><ISOAbbreviation>Mediators Inflamm</ISOAbbreviation></Journal><ArticleTitle>Pathogenic roles of macrophage migration inhibitory factor during dengue virus infection.</ArticleTitle><Pagination><StartPage>547094</StartPage><MedlinePgn>547094</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">547094</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2015/547094</ELocationID><Abstract><AbstractText>Dengue virus (DENV) infection is the most common cause of viral hemorrhagic fever, which can lead to life-threatening dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Hemorrhage and plasma leakage are two major hallmarks of DHF/DSS. Because the mechanisms causing these pathogenic changes are unclear, there is no effective therapy against DHF/DSS. In this review, we focus on the possible pathogenic effects of a pleiotropic cytokine, macrophage migration inhibitory factor (MIF), on the pathogenesis of DENV infection. MIF is a critical mediator of the host immune response and inflammation, and there is a correlation between the serum levels of MIF and disease severity in dengue patients. Furthermore, MIF knock-out mice exhibit less severe clinical disease and lethality. However, the role of MIF in the pathogenesis of DHF/DSS is not limited to immune cell recruitment. Recent evidence indicates that DENV infection induced MIF production and may contribute to vascular hyperpermeability and viral replication during DENV infection. The expression of both adhesion and coagulation molecules on MIF-stimulated monocytes and endothelial cells is also increased, which may contribute to inflammatory and anticoagulatory states during DHF/DSS. Therefore, blocking MIF production or its function may provide a solution for the treatment and prevention of DHF/DSS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chuang</LastName><ForeName>Yung-Chun</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, Medical College, National Cheng Kung University, Tainan 70101, Taiwan ; Center of Infectious Disease and Signaling Research, Medical College, National Cheng Kung University, Tainan 70101, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hong-Ru</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, Medical College, National Cheng Kung University, Tainan 70101, Taiwan ; The Institute of Basic Medical Sciences, Medical College, National Cheng Kung University, Tainan 70101, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Trai-Ming</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0003-3172-7432</Identifier><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, Medical College, National Cheng Kung University, Tainan 70101, Taiwan ; Center of Infectious Disease and Signaling Research, Medical College, National Cheng Kung University, Tainan 70101, Taiwan ; The Institute of Basic Medical Sciences, Medical College, National Cheng Kung University, Tainan 70101, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>03</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mediators Inflamm</MedlineTA><NlmUniqueID>9209001</NlmUniqueID><ISSNLinking>0962-9351</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008263">Macrophage Migration-Inhibitory Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>126547-89-5</RegistryNumber><NameOfSubstance UI="D018799">Intercellular Adhesion Molecule-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.3.-</RegistryNumber><NameOfSubstance UI="D019746">Intramolecular Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.3.2.1</RegistryNumber><NameOfSubstance UI="C515598">MIF protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002199" MajorTopicYN="N">Capillary Permeability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018799" MajorTopicYN="N">Intercellular Adhesion Molecule-1</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019746" MajorTopicYN="N">Intramolecular Oxidoreductases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008263" MajorTopicYN="N">Macrophage Migration-Inhibitory Factors</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25821355</ArticleId><ArticleId IdType="pmc">PMC4363636</ArticleId><ArticleId IdType="doi">10.1155/2015/547094</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>David J. R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proceedings of the National Academy of Sciences of the United States of America. 1966;56(1):72&#x2013;77. doi: 10.1073/pnas.56.1.72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.56.1.72</ArticleId><ArticleId IdType="pmc">PMC285677</ArticleId><ArticleId IdType="pubmed">5229858</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom B. R., Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 1966;153(3731):80&#x2013;82. doi: 10.1126/science.153.3731.80.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.153.3731.80</ArticleId><ArticleId IdType="pubmed">5938421</ArticleId></ArticleIdList></Reference><Reference><Citation>Asare Y., Schmitt M., Bernhagen J. The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis. Thrombosis and Haemostasis. 2013;109(3):391&#x2013;398. doi: 10.1160/th12-11-0831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/th12-11-0831</ArticleId><ArticleId IdType="pubmed">23329140</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H.-W., Bernhagen J., Bucala R., Lolis E. Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor. Proceedings of the National Academy of Sciences of the United States of America. 1996;93(11):5191&#x2013;5196. doi: 10.1073/pnas.93.11.5191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.11.5191</ArticleId><ArticleId IdType="pmc">PMC39220</ArticleId><ArticleId IdType="pubmed">8643551</ArticleId></ArticleIdList></Reference><Reference><Citation>Calandra T., Bernhagen J., Mitchell R. A., Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. The Journal of Experimental Medicine. 1994;179(6):1895&#x2013;1902. doi: 10.1084/jem.179.6.1895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.179.6.1895</ArticleId><ArticleId IdType="pmc">PMC2191507</ArticleId><ArticleId IdType="pubmed">8195715</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumagi T., Akbar F., Horiike N., Onji M. Increased serum levels of macrophage migration inhibitory factor in alcoholic liver diseases and their expression in liver tissues. Clinical Biochemistry. 2001;34(3):189&#x2013;193. doi: 10.1016/s0009-9120(01)00214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0009-9120(01)00214-4</ArticleId><ArticleId IdType="pubmed">11408016</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez R. S., Diepgen T. L., Neumann C., Sorg C. Detection of migration inhibitory factor (MIF) by a monoclonal antibody in the microvasculature of inflamed skin. Archives of Dermatological Research. 1990;282(6):374&#x2013;378. doi: 10.1007/bf00372087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf00372087</ArticleId><ArticleId IdType="pubmed">2260882</ArticleId></ArticleIdList></Reference><Reference><Citation>Calandra T., Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nature Reviews Immunology. 2003;3(10):791&#x2013;800. doi: 10.1038/nri1200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1200</ArticleId><ArticleId IdType="pmc">PMC7097468</ArticleId><ArticleId IdType="pubmed">14502271</ArticleId></ArticleIdList></Reference><Reference><Citation>Calandra T., Bernhagen J., Metz C. N., et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature. 1995;377(6544):68&#x2013;71. doi: 10.1038/377068a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/377068a0</ArticleId><ArticleId IdType="pubmed">7659164</ArticleId></ArticleIdList></Reference><Reference><Citation>Calandra T., Bucala R. Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock. Journal of Inflammation. 1995;47(1-2):39&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">8913928</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly S. C., Bucala R. Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease. Molecular Medicine Today. 1997;3(11):502&#x2013;507. doi: 10.1016/s1357-4310(97)01133-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1357-4310(97)01133-7</ArticleId><ArticleId IdType="pubmed">9430786</ArticleId></ArticleIdList></Reference><Reference><Citation>Str&#xfc;&#xdf;mann T., Tillmann S., Wirtz T., Bucala R., von Hundelshausen P., Bernhagen J. Platelets are a previously unrecognised source of MIF. Thrombosis and Haemostasis. 2013;110(5):1004&#x2013;1013. doi: 10.1160/th13-01-0049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/th13-01-0049</ArticleId><ArticleId IdType="pubmed">23846621</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng L., Metz C. N., Fang Y., et al. MIF signal transduction initiated by binding to CD74. The Journal of Experimental Medicine. 2003;197(11):1467&#x2013;1476. doi: 10.1084/jem.20030286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20030286</ArticleId><ArticleId IdType="pmc">PMC2193907</ArticleId><ArticleId IdType="pubmed">12782713</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X., Leng L., Wang T., et al. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity. 2006;25(4):595&#x2013;606. doi: 10.1016/j.immuni.2006.08.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.08.020</ArticleId><ArticleId IdType="pmc">PMC3707630</ArticleId><ArticleId IdType="pubmed">17045821</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarnowski M., Grymula K., Liu R., et al. Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts. Molecular Cancer Research. 2010;8(10):1328&#x2013;1343. doi: 10.1158/1541-7786.mcr-10-0288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.mcr-10-0288</ArticleId><ArticleId IdType="pmc">PMC2974061</ArticleId><ArticleId IdType="pubmed">20861157</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz V., Lue H., Kraemer S., et al. A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Letters. 2009;583(17):2749&#x2013;2757. doi: 10.1016/j.febslet.2009.07.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2009.07.058</ArticleId><ArticleId IdType="pmc">PMC2911026</ArticleId><ArticleId IdType="pubmed">19665027</ArticleId></ArticleIdList></Reference><Reference><Citation>Lue H., Kapurniotu A., Fingerle-Rowson G., et al. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cellular Signalling. 2006;18(5):688&#x2013;703. doi: 10.1016/j.cellsig.2005.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2005.06.013</ArticleId><ArticleId IdType="pubmed">16122907</ArticleId></ArticleIdList></Reference><Reference><Citation>Lue H., Thiele M., Franz J., et al. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene. 2007;26(35):5046&#x2013;5059. doi: 10.1038/sj.onc.1210318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1210318</ArticleId><ArticleId IdType="pubmed">17310986</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernhagen J., Krohn R., Lue H., et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nature Medicine. 2007;13(5):587&#x2013;596. doi: 10.1038/nm1567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1567</ArticleId><ArticleId IdType="pubmed">17435771</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee M., Borst O., Walker B., et al. Macrophage migration inhibitory factor limits activation-induced apoptosis of platelets via CXCR7-dependent akt signaling. Circulation Research. 2014;115(11):939&#x2013;949. doi: 10.1161/circresaha.115.305171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circresaha.115.305171</ArticleId><ArticleId IdType="pubmed">25266363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleemann R., Hausser A., Geiger G., et al. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature. 2000;408(6809):211&#x2013;216. doi: 10.1038/35041591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35041591</ArticleId><ArticleId IdType="pubmed">11089976</ArticleId></ArticleIdList></Reference><Reference><Citation>Morand E. F., Leech M. Macrophage migration inhibitory factor in rheumatoid arthritis. Frontiers in Bioscience. 2005;10(1):12&#x2013;22. doi: 10.2741/1501.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/1501</ArticleId><ArticleId IdType="pubmed">15576336</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernhagen J., Calandra T., Mitchell R. A., et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature. 1993;365(6448):756&#x2013;759. doi: 10.1038/365756a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/365756a0</ArticleId><ArticleId IdType="pubmed">8413654</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozza M., Satoskar A. R., Lin G., et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. The Journal of Experimental Medicine. 1999;189(2):341&#x2013;346. doi: 10.1084/jem.189.2.341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.189.2.341</ArticleId><ArticleId IdType="pmc">PMC2192995</ArticleId><ArticleId IdType="pubmed">9892616</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozza F. A., Gomes R. N., Japiass&#xfa; A. M., et al. Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis. Shock. 2004;22(4):309&#x2013;313. doi: 10.1097/01.shk.0000140305.01641.c8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.shk.0000140305.01641.c8</ArticleId><ArticleId IdType="pubmed">15377884</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Abed Y., Dabideen D., Aljabari B., et al. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. The Journal of Biological Chemistry. 2005;280(44):36541&#x2013;36544. doi: 10.1074/jbc.c500243200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.c500243200</ArticleId><ArticleId IdType="pubmed">16115897</ArticleId></ArticleIdList></Reference><Reference><Citation>Calandra T., Echtenacher B., Le Roy D., et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nature Medicine. 2000;6(2):164&#x2013;170. doi: 10.1038/72262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/72262</ArticleId><ArticleId IdType="pubmed">10655104</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcanti M. G., Mesquita J. S., Madi K., et al. Mif participates in Toxoplasma gondii-induced pathology following oral infection. PLoS ONE. 2011;6(9) doi: 10.1371/journal.pone.0025259.e25259</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025259</ArticleId><ArticleId IdType="pmc">PMC3178626</ArticleId><ArticleId IdType="pubmed">21977228</ArticleId></ArticleIdList></Reference><Reference><Citation>Herder C., Illig T., Baumert J., et al. Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984&#x2013;2002. Atherosclerosis. 2008;200(2):380&#x2013;388. doi: 10.1016/j.atherosclerosis.2007.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2007.12.025</ArticleId><ArticleId IdType="pubmed">18242614</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller I. I., M&#xfc;ller K. A. L., Sch&#xf6;nleber H., et al. Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response. PloS ONE. 2012;7(6) doi: 10.1371/journal.pone.0038376.e38376</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0038376</ArticleId><ArticleId IdType="pmc">PMC3367911</ArticleId><ArticleId IdType="pubmed">22693633</ArticleId></ArticleIdList></Reference><Reference><Citation>Zernecke A., Bernhagen J., Weber C. Macrophage migration inhibitory factor in cardiovascular disease. Circulation. 2008;117(12):1594&#x2013;1602. doi: 10.1161/circulationaha.107.729125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.107.729125</ArticleId><ArticleId IdType="pubmed">18362243</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson K. D., Templeton D. J., Cross J. V. Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment. The Journal of Immunology. 2012;189(12):5533&#x2013;5540. doi: 10.4049/jimmunol.1201161.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1201161</ArticleId><ArticleId IdType="pmc">PMC3518629</ArticleId><ArticleId IdType="pubmed">23125418</ArticleId></ArticleIdList></Reference><Reference><Citation>Morand E. F., Leech M., Bernhagen J. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nature Reviews Drug Discovery. 2006;5(5):399&#x2013;411. doi: 10.1038/nrd2029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd2029</ArticleId><ArticleId IdType="pubmed">16628200</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Pacheco B. D., Leng L., Bucala R., Ren J. Macrophage migration inhibitory factor plays a permissive role in the maintenance of cardiac contractile function under starvation through regulation of autophagy. Cardiovascular Research. 2013;99(3):412&#x2013;421. doi: 10.1093/cvr/cvt116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvt116</ArticleId><ArticleId IdType="pmc">PMC3732061</ArticleId><ArticleId IdType="pubmed">23674514</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou X. Q., Gao Y. W., Yang S. T., Wang C. Y., Ma Z. Y., Xia X. Z. Role of macrophage migration inhibitory factor in influenza H5N1 virus pneumonia. Acta Virologica. 2009;53(4):225&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pubmed">19941385</ArticleId></ArticleIdList></Reference><Reference><Citation>Delaloye J., de Bruin I. J. A., Darling K. E. A., et al. Increased macrophage migration inhibitory factor (MIF) plasma levels in acute HIV-1 infection. Cytokine. 2012;60(2):338&#x2013;340. doi: 10.1016/j.cyto.2012.07.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2012.07.027</ArticleId><ArticleId IdType="pubmed">22898393</ArticleId></ArticleIdList></Reference><Reference><Citation>Wauquier N., Becquart P., Padilla C., Baize S., Leroy E. M. Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Neglected Tropical Diseases. 2010;4(10, article e837) doi: 10.1371/journal.pntd.0000837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000837</ArticleId><ArticleId IdType="pmc">PMC2950153</ArticleId><ArticleId IdType="pubmed">20957152</ArticleId></ArticleIdList></Reference><Reference><Citation>Assun&#xe7;&#xe3;o-Miranda I., Amaral F. A., Bozza F. A., et al. Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection. The FASEB Journal. 2010;24(1):218&#x2013;228. doi: 10.1096/fj.09-139469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.09-139469</ArticleId><ArticleId IdType="pubmed">19776337</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L.-C., Lei H.-Y., Liu C.-C., et al. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. American Journal of Tropical Medicine and Hygiene. 2006;74(1):142&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">16407359</ArticleId></ArticleIdList></Reference><Reference><Citation>Henchal E. A., Putnak J. R. The dengue viruses. Clinical Microbiology Reviews. 1990;3(4):376&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC358169</ArticleId><ArticleId IdType="pubmed">2224837</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S. B., O'Rourke E. J. Antibody enhanced dengue virus infection in primate leukocytes. Nature. 1977;265:739&#x2013;741. doi: 10.1038/265739a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/265739a0</ArticleId><ArticleId IdType="pubmed">404559</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman A. L., Ennis F. A. Immunopathogenesis of dengue hemorrhagic fever. Virology. 1999;257(1):1&#x2013;6. doi: 10.1006/viro.1999.9656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1999.9656</ArticleId><ArticleId IdType="pubmed">10208914</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei H.-Y., Yeh T.-M., Liu H.-S., Lin Y.-S., Chen S.-H., Liu C.-C. Immunopathogenesis of dengue virus infection. Journal of Biomedical Science. 2001;8(5):377&#x2013;388. doi: 10.1159/000054058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000054058</ArticleId><ArticleId IdType="pubmed">11549879</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokisch V. A., Top F. H., Jr., Russell P. K., Dixon F. J., M&#xfc;ller-Eberhard H. J. The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. The New England Journal of Medicine. 1973;289(19):996&#x2013;1000. doi: 10.1056/nejm197311082891902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejm197311082891902</ArticleId><ArticleId IdType="pubmed">4742219</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang Y.-C., Lei H.-Y., Liu H.-S., Lin Y.-S., Fu T.-F., Yeh T.-M. Macrophage migration inhibitory factor induced by dengue virus infection increases vascular permeability. Cytokine. 2011;54(2):222&#x2013;231. doi: 10.1016/j.cyto.2011.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2011.01.013</ArticleId><ArticleId IdType="pubmed">21320786</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L.-C., Shyu H.-W., Lei H.-Y., et al. Dengue virus infection induced NF-&#x3ba;B-dependent macrophage migration inhibitory factor production. The American Journal of Infectious Diseases. 2008;4(1):22&#x2013;31. doi: 10.3844/ajidsp.2008.22.31.</Citation><ArticleIdList><ArticleId IdType="doi">10.3844/ajidsp.2008.22.31</ArticleId></ArticleIdList></Reference><Reference><Citation>Chareonsirisuthigul T., Kalayanarooj S., Ubol S. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. Journal of General Virology. 2007;88(2):365&#x2013;375. doi: 10.1099/vir.0.82537-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.82537-0</ArticleId><ArticleId IdType="pubmed">17251552</ArticleId></ArticleIdList></Reference><Reference><Citation>Regis E. G., Barreto-de-Souza V., Morgado M. G., et al. Elevated levels of macrophage migration inhibitory factor (MIF) in the plasma of HIV-1-infected patients and in HIV-1-infected cell cultures: a relevant role on viral replication. Virology. 2010;399(1):31&#x2013;38. doi: 10.1016/j.virol.2009.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2009.12.018</ArticleId><ArticleId IdType="pmc">PMC3140709</ArticleId><ArticleId IdType="pubmed">20085845</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero L. J., Nelson M., Srikiatkhachorn A., et al. Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(29):12048&#x2013;12053. doi: 10.1073/pnas.1101089108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1101089108</ArticleId><ArticleId IdType="pmc">PMC3141998</ArticleId><ArticleId IdType="pubmed">21730129</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjona A., Foellmer H. G., Town T., et al. Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. The Journal of Clinical Investigation. 2007;117(10):3059&#x2013;3066. doi: 10.1172/jci32218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci32218</ArticleId><ArticleId IdType="pmc">PMC1994625</ArticleId><ArticleId IdType="pubmed">17909632</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.-R., Lei H.-Y., Liu M.-T., et al. Autophagic machinery activated by dengue virus enhances virus replication. Virology. 2008;374(2):240&#x2013;248. doi: 10.1016/j.virol.2008.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2008.02.016</ArticleId><ArticleId IdType="pmc">PMC7103294</ArticleId><ArticleId IdType="pubmed">18353420</ArticleId></ArticleIdList></Reference><Reference><Citation>Heaton N. S., Randall G. Dengue virus-induced autophagy regulates lipid metabolism. Cell Host and Microbe. 2010;8(5):422&#x2013;432. doi: 10.1016/j.chom.2010.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2010.10.006</ArticleId><ArticleId IdType="pmc">PMC3026642</ArticleId><ArticleId IdType="pubmed">21075353</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.-R., Hu H.-Y., Kuo S.-H., et al. Dengue virus infection induces autophagy: an in vivo study. Journal of Biomedical Science. 2013;20(1, article 65) doi: 10.1186/1423-0127-20-65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-20-65</ArticleId><ArticleId IdType="pmc">PMC3848819</ArticleId><ArticleId IdType="pubmed">24011333</ArticleId></ArticleIdList></Reference><Reference><Citation>Djavaheri-Mergny M., Amelotti M., Mathieu J., et al. NF-&#x3ba;B activation represses tumor necrosis factor-&#x3b1;-induced autophagy. The Journal of Biological Chemistry. 2006;281(41):30373&#x2013;30382. doi: 10.1074/jbc.m602097200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.m602097200</ArticleId><ArticleId IdType="pubmed">16857678</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris J. Autophagy and cytokines. Cytokine. 2011;56(2):140&#x2013;144. doi: 10.1016/j.cyto.2011.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2011.08.022</ArticleId><ArticleId IdType="pubmed">21889357</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H.-J., Lee S. J., Kim S.-H., et al. IL-10 inhibits the starvation induced autophagy in macrophages via class I phosphatidylinositol 3-kinase (PI3K) pathway. Molecular Immunology. 2011;48(4):720&#x2013;727. doi: 10.1016/j.molimm.2010.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2010.10.020</ArticleId><ArticleId IdType="pubmed">21095008</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang Y.-C., Su W.-H., Lei H.-Y., et al. Macrophage migration inhibitory factor induces autophagy via reactive oxygen species generation. PLoS ONE. 2012;7(5) doi: 10.1371/journal.pone.0037613.e37613</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037613</ArticleId><ArticleId IdType="pmc">PMC3358253</ArticleId><ArticleId IdType="pubmed">22629429</ArticleId></ArticleIdList></Reference><Reference><Citation>Aveleira C. A., Lin C.-M., Abcouwer S. F., Ambr&#xf3;sio A. F., Antonetti D. A. TNF-&#x3b1; signals through PKC&#x3b6;/NF-&#x3ba;B to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes. 2010;59(11):2872&#x2013;2882. doi: 10.2337/db09-1606.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db09-1606</ArticleId><ArticleId IdType="pmc">PMC2963546</ArticleId><ArticleId IdType="pubmed">20693346</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann S., Grasberger H., Jung P., et al. The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression. European Journal of Medical Research. 2002;7(4):171&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">12010652</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavard J., Gutkind J. S. VEGF Controls endothelial-cell permeability promoting &#x3b2;-arrestin-dependent endocytosis VE-cadherin. Nature Cell Biology. 2006;8(11):1223&#x2013;1234. doi: 10.1038/ncb1486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1486</ArticleId><ArticleId IdType="pubmed">17060906</ArticleId></ArticleIdList></Reference><Reference><Citation>Huveneers S., Oldenburg J., Spanjaard E., et al. Vinculin associates with endothelial VE-cadherin junctions to control force-dependent remodeling. Journal of Cell Biology. 2012;196(5):641&#x2013;652. doi: 10.1083/jcb.201108120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201108120</ArticleId><ArticleId IdType="pmc">PMC3307691</ArticleId><ArticleId IdType="pubmed">22391038</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu W., London N. R., Gibson C. C., et al. Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability. Nature. 2012;492(7428):252&#x2013;255. doi: 10.1038/nature11603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11603</ArticleId><ArticleId IdType="pmc">PMC3521847</ArticleId><ArticleId IdType="pubmed">23143332</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H. R., Chuang Y. C., Chao C. H., Yeh T. M. Macrophage migration inhibitory factor induces vascular leakage via autophagy. Biology Open. 2015;4(2):244&#x2013;252. doi: 10.1242/bio.201410322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/bio.201410322</ArticleId><ArticleId IdType="pmc">PMC4365493</ArticleId><ArticleId IdType="pubmed">25617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin M. A., Haas C. S., Zhu K., et al. Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NF&#x3ba;B. Blood. 2006;107(6):2252&#x2013;2261. doi: 10.1182/blood-2005-05-2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2005-05-2011</ArticleId><ArticleId IdType="pmc">PMC1472703</ArticleId><ArticleId IdType="pubmed">16317091</ArticleId></ArticleIdList></Reference><Reference><Citation>Shyu L.-Y., Yeh T.-M., Chang H.-H., et al. Macrophage migration inhibitory factor induces ICAM-1and thrombomobulin expression in vitro . Thrombosis Research. 2012;129(1):43&#x2013;49. doi: 10.1016/j.thromres.2011.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2011.08.011</ArticleId><ArticleId IdType="pubmed">21890178</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh T.-M., Liu S.-H., Lin K.-C., et al. Dengue virus enhances thrombomodulin and ICAM-1 expression through the macrophage migration inhibitory factor induction of the MAPK and PI3K signaling pathways. PLoS ONE. 2013;8(1) doi: 10.1371/journal.pone.0055018.e55018</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0055018</ArticleId><ArticleId IdType="pmc">PMC3557271</ArticleId><ArticleId IdType="pubmed">23383040</ArticleId></ArticleIdList></Reference><Reference><Citation>Butthep P., Chunhakan S., Tangnararatchakit K., Yoksan S., Pattanapanyasat K., Chuansumrit A. Elevated soluble thrombomodulin in the febrile stage related to patients at risk for dengue shock syndrome. The Pediatric Infectious Disease Journal. 2006;25(10):894&#x2013;897. doi: 10.1097/01.inf.0000237918.85330.b9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000237918.85330.b9</ArticleId><ArticleId IdType="pubmed">17006283</ArticleId></ArticleIdList></Reference><Reference><Citation>Morand E. F. New therapeutic target in inflammatory disease: macrophage migration inhibitory factor. Internal Medicine Journal. 2005;35(7):419&#x2013;426. doi: 10.1111/j.1445-5994.2005.00853.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1445-5994.2005.00853.x</ArticleId><ArticleId IdType="pubmed">15958113</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>